The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents
Abstract
Diabetic ketoacidosis (DKA) is the leading cause of morbidity and mortality in children with type 1 diabetes mellitus (TIDM). Mortality is predominantly related to the occurrence of cerebral edema; only a minority of deaths in DKA are attributed to other causes. Cerebral edema occurs in ∼0.3% to 1% of all episodes of DKA, and its etiology, pathophysiology, and ideal method of treatment are poorly understood. There is debate as to whether physicians treating DKA can prevent or predict the occurrence of cerebral edema and the appropriate site(s) for children with DKA to be managed. There is agreement that prevention of DKA and reduction of its incidence should be a goal in managing children with diabetes.To explore these issues, the Lawson Wilkins Pediatric Endocrine Society (LWPES) and the European Society for Pediatric Endocrinology (ESPE) convened a panel‖ of expert physicians for a consensus conference. The meeting was chaired by Mark A. Sperling, MD, representing LWPES, and David B. Dunger, MD, representing ESPE. The Consensus statement was developed with close partnership between the ESPE and LWPES and the International Society for Pediatric and Adolescent Diabetes, all 3 organizations being represented by members who participated in the writing process. The statement also was endorsed by related organizations; the Juvenile Diabetes Research Foundation International, the World Federation of Pediatric Intensive and Critical Care Societies, the European Society for Pediatric Critical Care, the European Society of Pediatric and Neonatal Intensive Care, and the Australian Pediatric Endocrine Group were represented by invited participants.Each of the major topics had a presenter and recorder, responsible for review of the literature and providing evidence-based recommendations according to criteria used by the American Diabetes Association (see Appendix; levels of evidence are indicated in capital letters, in parentheses).1 Type 2 diabetes was not considered. All participants contributed significantly to the development of consensus.This document summarizes the final consensus reached and represents the current “state of the art.”DKA is caused by a decrease in effective circulating insulin associated with elevations in counterregulatory hormones including glucagon, catecholamines, cortisol, and growth hormone. This leads to increased glucose production by the liver and kidney and impaired peripheral glucose utilization, with resultant hyperglycemia and hyperosmolality. Increased lipolysis, with ketone body (β-hydroxybutyrate [β-OHB] and acetoacetate) production causes ketonemia and metabolic acidosis. Hyperglycemia and acidosis result in osmotic diuresis, dehydration, and obligate loss of electrolytes. The biochemical criteria for the diagnosis of DKA include hyperglycemia (blood glucose: >11 mmol/L [∼200 mg/dL]) with a venous pH <7.3 and/or bicarbonate <15 mmol/L. There is associated glycosuria, ketonuria, and ketonemia. Rarely, young or partially treated children as well as pregnant adolescents may present with near-normal glucose values (“euglycemic ketoacidosis”).2DKA is generally categorized by the severity of the acidosis, varying from mild (venous pH: <7.30; bicarbonate concentration: <15 mmol/L) to moderate (pH: <7.2; bicarbonate: <10) to severe (pH: <7.1; bicarbonate: <5).3,4There is wide geographic variation in the frequency of DKA at diabetes onset, and rates correlate inversely with regional incidence of TIDM. Reported frequencies range between 15% and 67% in Europe and North America and may be more common in developing countries (A).5,6 In Canada and Europe, hospitalization rates for DKA in established and new patients with TIDM have remained stable at ∼10 per 100 000 children over the past 20 years, but severity may be decreasing (B).7,8DKA at onset of TIDM is more common in younger children (<4 years of age), children without a first-degree relative with TIDM, and those from families of lower socioeconomic status (A).4,9 High-dose glucocorticoids, atypical antipsychotics, diazoxide, and some immunosuppressive drugs have been reported to precipitate DKA in individuals not diagnosed previously with TIDM (B).10,11The risk of DKA in established TIDM is 1% to 10% per patient per year (A).12–15 Risk is increased in children with poor metabolic control or previous episodes of DKA, peripubertal and adolescent girls, children with psychiatric disorders (including those with eating disorders), and those with difficult family circumstances (including lower socioeconomic status and lack of appropriate health insurance).16 Inappropriate interruption of insulin-pump therapy also leads to DKA.12,14Children whose insulin is administered by a responsible adult rarely have episodes of DKA (C),17 and 75% of episodes of DKA beyond diagnosis probably are associated with insulin omission or treatment error.17,18 The remainder are due to inadequate insulin therapy during intercurrent illness (B).18–20Reported mortal
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke
Manley, G. T., Fujimura, M., Ma, T., Noshita, N., Filiz, F., Bollen, A. W., Chan, P., & Verkman, A. S. (2000) · Nature Medicine · doi:10.1038/72256 · Cited by 1,507
Effects of insulin in relatives of patients with type 1 diabetes mellitus
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012350 · Cited by 836
Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability
Abbott, N. J. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007074420772 · Cited by 803
Risk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
Glaser, N., Barnett, P., McCaslin, I., Nelson, D., Trainor, J., Louie, J., Kaufman, F., Quayle, K., Roback, M., Malley, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101253440404 · Cited by 779
Self-citationRisk Factors for Cerebral Edema in Children with Diabetic Ketoacidosis
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442014 · Cited by 533
Morris, A. D., Boyle, D. I., McMahon, A. D., Greene, S. A., MacDonald, T. M., & Newton, R. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06234-x · Cited by 507
Grey, M., Boland, E. A., Davidson, M., Li, J., & Tamborlane, W. V. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.106568 · Cited by 503
Predictors of Acute Complications in Children With Type 1 Diabetes
Rewers, A. (2002) · JAMA · doi:10.1001/jama.287.19.2511 · Cited by 496
Regulation of Cell Volume in Health and Disease
McManus, M. L., Churchwell, K. B., & Strange, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511093331906 · Cited by 441
Atchley, D. W., Loeb, R. F., Richards, D. W., Benedict, E. M., & Driscoll, M. E. (1933) · Journal of Clinical Investigation · doi:10.1172/jci100504 · Cited by 396
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Care of Children and Adolescents With Type 1 Diabetes
Silverstein, J., Klingensmith, G., Copeland, K., Plotnick, L., Kaufman, F., Laffel, L., Deeb, L., Grey, M., Anderson, B., Holzmeister, L. A., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.186 · Cited by 1,312
Wolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M. A., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12701 · Cited by 710
Self-citationDefinition, epidemiology and classification of diabetes in children and adolescents
Craig, M. E., Hattersley, A., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00568.x · Cited by 461
Genetics of the HLA Region in the Prediction of Type 1 Diabetes
Noble, J. A., & Valdes, A. M. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0223-x · Cited by 460
Metadata
- Authors
- Dunger, D. B., Sperling, M. A., Acerini, C. L., Bohn, D. J., Daneman, D., Danne, T. P. A., Glaser, N. S., Hanas, R., Hintz, R. L., Levitsky, L. L., Savage, M. O., Tasker, R. C., & Wolfsdorf, J. I.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2004-02-01
- Volume
- 113
- Issue
- 2
- Pages
- e133-e140
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2118872672
- Cited by
- 296
- References
- 82
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents. https://app.cochat.ai/papers/10.1542/peds.113.2.e133
- The paper
- Dunger, D. B., Sperling, M. A., Acerini, C. L., Bohn, D. J., Daneman, D., Danne, T. P. A., Glaser, N. S., Hanas, R., Hintz, R. L., Levitsky, L. L., Savage, M. O., Tasker, R. C., & Wolfsdorf, J. I. (2004). European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents. Pediatrics. https://doi.org/10.1542/peds.113.2.e133
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.